ORGANIC CATION TRANSPORTER 1 (OCT1) EFFLUXES CARNITINE AND ACYLCARNITINES FROM THE LIVER TO BLOOD

被引：0
|
作者：
Kim, Hye In [1 ]
Lu, Wenyun [2 ]
Bennett, Michael [3 ]
Rabinowitz, Joshua [2 ]
Hand, Nicholas [1 ]
Rader, Daniel [1 ]
机构：
[1] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[2] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA
[3] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2016年 / 117卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
60
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [21] Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration
    Tzvetkov, Mladen V.
    Pereira, Joao N. dos Santos
    Meineke, Ingolf
    Saadatmand, Ali R.
    Stingl, Julia C.
    Brockmoeller, Juergen
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (05) : 666 - 678
  • [22] Roles of a choline uptake transporter, the organic cation transporter 1 (OCT1), in pathogenesis of primary biliary cirrhosis: OCT1 expression and its single-nucleotide polymorphism
    Kohjima, Motoyuki
    Ohishi, Yuki
    Fukushima, Nobuyoshi
    Nakamura, Tsukasa
    Kurokawa, Miho
    Iwata, Mayuko
    Yoshimoto, Tsuyoshi
    Fukuizumi, Kunitaka
    Nakamura, Minoru
    Ishibashi, Hiromi
    Honda, Akira
    Matsuzaki, Yasushi
    Nozaki, Yuichi
    Nakajima, Atsushi
    Enjoji, Munechika
    Nakamuta, Makoto
    HEPATOLOGY, 2012, 56 : 1128A - 1128A
  • [23] ROLES OF A CHOLINE UPTAKE TRANSPORTER, THE ORGANIC CATION TRANSPORTER 1 (OCT1), IN PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS: OCT1 EXPRESSION AND ITS SINGLE-NUCLEOTIDE POLYMORPHISM
    Nakamuta, M.
    Kohjima, M.
    Ohishi, Y.
    Fukushima, N.
    Yoshimoto, T.
    Fukuizumi, K.
    Nakamura, M.
    Ishibashi, H.
    Honda, A.
    Matsuzaki, Y.
    Nozaki, Y.
    Nakajima, A.
    Nomura, H.
    Enjoji, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S378 - S379
  • [24] The human organic cation transporter OCT1 and its role as a target for drug responses
    Brosseau, Nicolas
    Ramotar, Dindial
    DRUG METABOLISM REVIEWS, 2019, 51 (04) : 389 - 407
  • [25] Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
    Shu, Y
    Leabman, MK
    Feng, B
    Mangravite, LM
    Huang, CC
    Stryke, D
    Kawamoto, M
    Johns, SJ
    DeYoung, J
    Carlson, E
    Ferrin, TE
    Herskowitz, I
    Giacomini, KM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) : 5902 - 5907
  • [26] Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake
    Choi, Min-Koo
    Song, Im-Sook
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (03) : 170 - 178
  • [27] Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1
    Meyer, Marleen J.
    Neumann, Viktoria E.
    Friesacher, Hannah Rosa
    Zdrazil, Barbara
    Brockmoeler, Jurgen
    Tzvetkov, Mladen V.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (21) : 9890 - 9905
  • [28] Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to Children
    Hahn, D.
    Emoto, C.
    Vinks, A. A.
    Fukuda, T.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (04) : 424 - 424
  • [29] Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to Children
    Hahn, David
    Emoto, Chie
    Vinks, Alexander A.
    Fukuda, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (01) : 23 - 26
  • [30] Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB)
    Sekhar, Gayathri N.
    Georgian, Ana R.
    Sanderson, Lisa
    Vizcay-Barrena, Gema
    Brown, Rachel C.
    Muresan, Paula
    Fleck, Roland A.
    Thomas, Sarah A.
    PLOS ONE, 2017, 12 (03):
12345